Search

everythinglearnresearchcommunity

for

Search:↓

Women with thinning hair have thinner hair strands than women without hair loss.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Most patients experience temporary hair loss after ECMO, but it usually grows back within 6 months without treatment.

Latanoprost can make eyelashes longer, thicker, and darker.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Crash dieting can cause hair loss due to severe calorie restriction.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

COVID-19 infection may cause hair loss.

Monocytes might be linked to hair loss after COVID-19.

Some patients temporarily lost hair after a certain bowel surgery, but it grew back without needing special treatment.

Topical Minoxidil is effective for hair loss after COVID-19.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.